ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,229,918 | -26.7% | 26,662 | -36.3% | 0.06% | -10.6% |
| Q1 2023 | $1,677,944 | +52.9% | 41,844 | +76.7% | 0.07% | +65.0% |
| Q4 2022 | $1,097,187 | -78.5% | 23,682 | -80.8% | 0.04% | -77.7% |
| Q3 2022 | $5,101,000 | +471.2% | 123,189 | +902.0% | 0.18% | +426.5% |
| Q1 2022 | $893,000 | -15.7% | 12,294 | -2.4% | 0.03% | -17.1% |
| Q4 2021 | $1,059,000 | -90.8% | 12,590 | -90.2% | 0.04% | -90.3% |
| Q3 2021 | $11,553,000 | -22.3% | 128,100 | -17.8% | 0.42% | +24.4% |
| Q2 2021 | $14,862,000 | +1259.7% | 155,864 | +1523.6% | 0.34% | +900.0% |
| Q1 2021 | $1,093,000 | – | 9,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |